SHP2 phosphatase as a novel therapeutic target for melanoma treatment

Melanoma ranks among the most aggressive and deadly human cancers. Although a number of targeted therapies are available, they are effective only in a subset of patients and the emergence of drug resistance often reduces durable responses. Thus there is an urgent need to identify new therapeutic tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruo-Yu, Yu, Zhi-Hong, Zeng, Lifan, Zhang, Sheng, Bai, Yunpeng, Miao, Jinmin, Chen, Lan, Xie, Jingwu, Zhang, Zhong-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342016/
https://www.ncbi.nlm.nih.gov/pubmed/27650545
http://dx.doi.org/10.18632/oncotarget.12074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342016/
https://www.ncbi.nlm.nih.gov/pubmed/27650545
http://dx.doi.org/10.18632/oncotarget.12074

Ejemplares similares